Ayr Wellness Inc.
AYRWF
$0.21
-$0.01-4.55%
| Weiss Ratings | AYRWF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | AYRWF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Fair | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | AYRWF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.56 | |||
| Price History | AYRWF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -43.40% | |||
| 30-Day Total Return | -50.13% | |||
| 60-Day Total Return | -60.38% | |||
| 90-Day Total Return | -91.06% | |||
| Year to Date Total Return | -59.06% | |||
| 1-Year Total Return | -88.89% | |||
| 2-Year Total Return | -78.78% | |||
| 3-Year Total Return | -98.17% | |||
| 5-Year Total Return | -97.22% | |||
| 52-Week High % Change | -93.64% | |||
| 52-Week Low % Change | 4.27% | |||
| Price | AYRWF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $3.46 | |||
| 52-Week Low Price | $0.21 | |||
| 52-Week Low Price (Date) | Mar 06, 2025 | |||
| 52-Week High Price (Date) | Apr 30, 2024 | |||
| Valuation | AYRWF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 25.82M | |||
| Enterprise Value | 596.66M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -2.24 | |||
| Earnings Per Share Growth | -61.43% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.05 | |||
| Price/Book (Q) | 0.05 | |||
| Enterprise Value/Revenue (TTM) | 1.28 | |||
| Price | $0.21 | |||
| Enterprise Value/EBITDA (TTM) | 11.76 | |||
| Enterprise Value/EBIT | -24.99 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | AYRWF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 114.84M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | AYRWF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | -- | |||
| Address | 2601 South Bayshore Drive Miami, FL 33133 | |||
| Website | www.ayrwellness.com | |||
| Country | United States | |||
| Year Founded | 2017 | |||
| Profitability | AYRWF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -5.14% | |||
| Profit Margin | -48.24% | |||
| Management Effectiveness | AYRWF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -1.03% | |||
| Return on Equity | -- | |||
| Income Statement | AYRWF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 464.51M | |||
| Total Revenue (TTM) | 464.51M | |||
| Revenue Per Share | $4.04 | |||
| Gross Profit (TTM) | 190.22M | |||
| EBITDA (TTM) | 50.73M | |||
| EBIT (TTM) | -23.88M | |||
| Net Income (TTM) | -224.11M | |||
| Net Income Avl. to Common (TTM) | -224.11M | |||
| Total Revenue Growth (Q YOY) | -0.06% | |||
| Earnings Growth (Q YOY) | -162.13% | |||
| EPS Diluted (TTM) | -2.24 | |||
| EPS Diluted Growth (Q YOY) | -75.34% | |||
| Balance Sheet | AYRWF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 50.58M | |||
| Cash Per Share (Q) | $0.44 | |||
| Total Current Assets (Q) | 187.86M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 526.77M | |||
| Current Ratio (Q) | 1.593 | |||
| Book Value Per Share (Q) | $4.66 | |||
| Total Assets (Q) | 1.42B | |||
| Total Current Liabilities (Q) | 117.95M | |||
| Total Debt (Q) | 603.88M | |||
| Total Liabilities (Q) | 894.43M | |||
| Total Common Equity (Q) | 541.09M | |||
| Cash Flow | AYRWF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -30.25M | |||
| Cash from Financing (TTM) | -13.07M | |||
| Net Change in Cash (TTM) | -22.27M | |||
| Levered Free Cash Flow (TTM) | -41.95M | |||
| Cash from Operations (TTM) | 21.05M | |||
